Menu
close
Menu
close
Menu
close

  • Accelerate your research

    with our C. elegans expertise
    and services

    C.Elegans

    C. elegans assays adds value beyond in vitro and mammal testing for drug development and research.


  • Accelerate your research

    with our C. elegans expertise
    and services

    Mircrobiome

    A fast and reliable method of animal testing for chronic effects of a large number of microbial candidates.

  • Accelerate your research

    with our C. elegans expertise
    and services

    Ageing

    Our approach generates reproducible data on the impact your compounds have on quality of life and the slowing of ageing.

  • Accelerate your research

    with our C. elegans expertise
    and services

    Neurodegeneration

    Our approach generates reproducible data on the impact your compounds have on quality of life and the slowing of ageing

  • Accelerate your research

    with our C. elegans expertise
    and services

    Biotech/Pharma

    Our approach generates reproducible data on the impact your compounds have on quality of life and the slowing of ageing

Accelerate your research
with our C. elegans expertise and services

C.elegans
C. elegans assays add value beyond in vitro and mammal testing for drug development and research.

Why C. elegans?
Accelerate your research
with our C. elegans expertise and services

Microbiome
A fast and reliable method of animal testing for chronic effects of a large number of microbial candidates.

Find out more
Accelerate your research
with our C. elegans expertise and services

Ageing
Our approach generates reproducible data on the impact your compounds have on quality of life and the slowing of ageing.

Find out more
Accelerate your research
with our C. elegans expertise and services

Neurodegeneration
Use a proven animal model to test compounds that could slow the degeneration of neurons

Find out more
Accelerate your research
with our C. elegans expertise and services

Biotech/Pharma
Use C. elegans to demonstrate efficacy and safety and to validate targets.

Find out more
Slider

Accelerate your research

with our C. elegans expertise and services

  • Accelerate your research

    with our C. elegans expertise and services

    C. elegans

    C. elegans assays adds value beyond in-vitro and mammal testing for drug development and research


  • Accelerate your research

    with our C. elegans expertise and services

    Microbiome

    A fast and reliable method of animal testing for chronic effects of a large number of microbial candidates.

  • Accelerate your research

    with our C. elegans expertise and services

    Ageing

    C. elegans assays adds value beyond in-vitro and mammal testing for drug development and research


  • Accelerate your research

    with our C. elegans expertise and services

    Neurodegeneration

    Use a proven animal model to test compounds that could slow the degeneration of neuron

  • Accelerate your research

    with our C. elegans expertise and services

    Biotech/Pharma

    Use C. elegans to demonstrate efficacy and safety and to validate targets.

SERVICES

Contract lab services for 
your research area

Contract lab services for your research area

Our customised C. elegans studies help industry leaders generate high-quality,reproducible data to answer their research questions in these areas.

  • Microbiome

    A powerful whole organism model for microbiome research

  • Neurodegeneration

    A proven whole organism model for neurodegenerative disease research

  • Toxicity

    A powerful whole organism model for detecting toxicity for the environment and human health

  • Ageing

    A powerful whole organism model for accelerating ageing research

  •   Transgenics

    Making transgenics requires specialist equipment, expertise and time.

SERVICES

Contract lab services for 
your research area

Contract lab services for your research area

Our customised C. elegans studies help industry leaders generate high-quality,
reproducible data to answer their research questions in these areas.

  • Microbiome

    A powerful whole organism model for microbiome
    research

    Neurodegeneration

    A proven whole organism model for neurodegenerative disease research

    Toxicity

    A powerful whole organism model for detecting toxicity for the environment and human health

  • Ageing

    A powerful whole organism model for microbiome research

    Transgenics

    A proven whole organism model for neurodegenerative disease research

  • Microbiome

    A powerful whole organism model for microbiome research

  • Neurodegeneration

    A proven whole organism model for neurodegenerative disease research

  • Toxicity

    A powerful whole organism model for detecting toxicity for the environment and human health

  • Ageing

    A powerful whole organism model for accelerating ageing research

  •   Transgenics

    Making transgenics requires specialist equipment, expertise and time.

SERVICES

Contract lab services for 
your research area

Contract lab services for your research area

Our customised C. elegans studies help industry leaders generate high-quality, 
reproducible data to answer their research questions in these areas.

WHO WE HELP

We provide invaluable tools to accelerate R&D across different industries

Our team has rich experience helping researchers in these sectors
biotech

Biotech

Biotech professionals must progress their drug discovery R&D timelines fast in order to make the best use of their funding and IP. We help you take the jump from petri dish to mammal in vivo models with confidence and more quickly than going straight to rodent models.

Find out more

biotech

Health and Manufacturing

Consumer goods, manufacturing and other industries investing in R&D want to put the best quality, eco-friendly products out on the market. However, testing your compounds for impact on environmental and human health can lead to overly complex, ethically challenging and time-consuming studies with animal models. C. elegans offer an ethical approach that can get the data you need on your compound in as little as three weeks.

Find out more

biotech

Pharma

The pressure on drug developers is greater than ever and pharma need to look to innovative new tools to stay ahead of the competition. C. elegans offer an NC3Rs-approved avenue to fast-track preclinical research, to save you from or reduce your reliance on high-investment rodent studies.

Find out more

biotech

Academia

You want to progress your research and improve lab operations but access to the right technologies, technological expertise and the time to juggle everything is challenging. We offer high-quality C. elegans lab services, transgenics services, and machine leasing of our unique automated technology to help you stay top of your field.

Find out more

Biotech

Take the jump from petri dish to in vivo models with confidence.

Health and Manufacturing

Helping industrial R&D get the data they need on their compounds in as little as three weeks.

Pharma

Fast-track your preclinical research and de-risk high-investment rodent studies.

Academia

High-quality C. elegans lab services and machine leasing of our unique automated technology to help you stay top of your field.

  • Biotech

    Take the jump from petri dish to in vivo models with confidence.

  • Health Products and Manufacturing

    Helping industrial R&D get the data they need on their compounds in as little as three weeks.

  • Pharma

    Fast-track your preclinical research and de-risk high-investment rodent studies.

  • Academia

    High-quality C. elegans lab services and machine leasing of our unique automated technology to help you stay top of your field.

WHO WE HELP

We provide invaluable tools to accelerate 
R&D across different industries

Our team has rich experience helping researchers in these sectors
Biotech
Health and Manufacturing
Pharma
Academia

Biotech

You want to progress your research and improve lab operations but access to the right technologies, technological expertise and the time to juggle everything is challenging. We offer high-quality C. elegans lab services, transgenics services, and machine leasing of our unique automated technology to help you access the resources you need to stay top of your field.

Read More

Health and Manufacturing

You want to progress your research and improve lab operations but access to the right technologies, technological expertise and the time to juggle everything is challenging. We offer high-quality C. elegans lab services, transgenics services, and machine leasing of our unique automated technology to help you access the resources you need to stay top of your field.

Read More

Pharma

You want to progress your research and improve lab operations but access to the right technologies, technological expertise and the time to juggle everything is challenging. We offer high-quality C. elegans lab services, transgenics services, and machine leasing of our unique automated technology to help you access the resources you need to stay top of your field.

Read More

Academia

You want to progress your research and improve lab operations but access to the right technologies, technological expertise and the time to juggle everything is challenging. We offer high-quality C. elegans lab services, transgenics services, and machine leasing of our unique automated technology to help you access the resources you need to stay top of your field.

Read More

how it works

Our typical 
assay workflow

We deliver top-quality customised service from project design to project end

Design your experiments in consultation
with our expert team to answer your
research question

We test your compounds for compatibility
with our drug delivery system

We test your compounds for acute and developmental reproductive toxicity

We monitor worm mobility to reveal efficacy and
chronic toxicity of your compound

We evaluate the data to ensure it answers your
research question and deliver a clear, data-rich
report you can present with confidence

HOW IT WORKS

We test your compounds for acute and
developmental reproductive toxicity

Our typical 
assay workflow

We deliver top-quality customised service from project design to project end

Design your experiments in consultation
with our expert team to answer your
research question

We test your compounds for compatibility with our drug delivery system

We test your compounds for acute and
developmental reproductive toxicity

We monitor worm mobility to reveal efficacy and chronic toxicity of your compound

We evaluate the data to ensure it answers your research question and deliver a clear, data-rich report you can present with confidence

Design your experiments in consultation
with our expert team to answer your
research question

We test your compounds for compatibilit with our drug delivery system

We test your compounds for acute and
developmental reproductive toxicity

We monitor worm mobility to reveal efficacy and chronic toxicity of your compound

We evaluate the data to ensure it answers your research question and deliver a clear, data-rich report you can present with confidence

  • "Pleased with the professional, efficient level of service we received from Magnitude Biosciences. We were happy to see reproducible and consistent data that has real potential for future screening projects."
    Dr Jennifer Tullet
    Senior Lecturer, University of Kent.
  • 'Magnitude were very collaborative, efficient and flexible as the experiments progressed. We were impressed with the power of the automated imaging technology and the speed at which we obtained the results which helped us to efficiently prioritise key compounds.''
    Dr Peter Hamley
    CSO, Samsara Therapeutics - Samsara is a company discovering new medicines for healthy ageing
  • ''The team at Magnitude Biosciences revealed the power of the C. elegans system in the early stages of drug development. They made us aware of the possibility and merit of using a variety of transgenics techniques in C. elegans to test the positive effects of peptides in models of neurodegeneration. We hope there will be future opportunities to partner with Magnitude Biosciences to help us develop the next generation of therapies.''
    Dr Penny Hayward
    Principal Scientist, PhoreMost Ltd. PhoreMost has developed the protein interference SITESEEKER® platform to drug the undruggable in oncology and ageing.

Dr Jennifer Tullet

Pleased with the professional, efficient level of service we received from Magnitude Biosciences. We were happy to see reproducible and consistent data that has real potential for future screening projects.

Senior Lecturer / University of Kent

Dr Peter Hamley

Magnitude were very collaborative, efficient and flexible as the experiments progressed. We were impressed with the power of the automated imaging technology and the speed at which we obtained the results which helped us to efficiently prioritise key compounds.

CSO, Samsara Therapeutics / Samsara is a company discovering new medicines for healthy ageing

Dr Penny Hayward

The team at Magnitude Biosciences revealed the power of the C. elegans system in the early stages of drug development. They made us aware of the possibility and merit of using a variety of transgenics techniques in C. elegans to test the positive effects of peptides in models of neurodegeneration. We hope there will be future opportunities to partner with Magnitude Biosciences to help us develop the next generation of therapies.

Principal Scientist / PhoreMost Ltd. PhoreMost has developed the protein interference SITESEEKER® platform to drug the undruggable in oncology and ageing.

  • "Pleased with the professional, efficient level of service we received from Magnitude Biosciences. We were happy to see reproducible and consistent data that has real potential for future screening projects."

    Dr Jennifer Tullet
    Senior Lecturer, University of Kent.

  • "Magnitude were very collaborative, efficient and flexible as the experiments progressed. We were impressed with the power of the automated imaging technology and the speed at which we obtained the results which helped us to efficiently prioritise key compounds.''

    Dr Peter Hamley
    CSO, Samsara Therapeutics - Samsara is a company discovering new medicines for healthy ageing

  • ''The team at Magnitude Biosciences revealed the power of the C. elegans system in the early stages of drug development. They made us aware of the possibility and merit of using a variety of transgenics techniques in C. elegans to test the positive effects of peptides in models of neurodegeneration. We hope there will be future opportunities to partner with Magnitude Biosciences to help us develop the next generation of therapies.''

    Dr Penny Hayward
    Principal Scientist, PhoreMost Ltd. PhoreMost has developed the protein interference SITESEEKER® platform to drug the undruggable in oncology and ageing.

News and blog

The latest from
Magnitude Biosciences

2 February 2023
AB Biotek works with Magnitude Biosciences to accelerate probiotic development
Guillermo Navarrete
No Comments

Magnitude Biosciences partnered with AB Biotek Human Nutrition & Health (ABB HNH), the global leader in yeast probiotics and postbiotics. Recently we had the pleasure of hosting Maria Tintoré and Carlos de Lecea from AB Biotek at our lab in Sedgefield, UK. There is growing evidence on how health problems and diseases are linked to […]

Read More
2 February 2023
Case Study - AB Biotek works with Magnitude Biosciences to accelerate probiotic development
Guillermo Navarrete
No Comments

Download the full case study here and learn how AB Biotek and Magnitude Biosciences collaborate to develop a new generation of probiotics.

Read More
5 December 2022
Pharmaceutical company Lundbeck in collaboration with Magnitude Biosciences on innovative new platform to test interventions for neurodegenerative disease
Jessica Evans
No Comments

Lundbeck collaborates with Magnitude on innovate platform to test neurodegenerative disease interventions

Read More
15 November 2022
Magnitude Biosciences secures new investment to accelerate scaling of its specialist anti-ageing research services
Mira Nair
No Comments

Magnitude Biosciences Limited, a specialist provider of C. elegans research services to the longevity, nutraceuticals and pharmaceutical industries, has closed a fourth round of investment to accelerate the scaling of its business.

Read More
7 October 2022
Magnitude Biosciences Appoints New CEO Fozia Saleem to Drive Growth
Jessica Evans
No Comments

North East UK Biotech Magnitude Biosciences announces new CEO, Fozia Saleem, to accelerate the growth of the world leading C. elegans CRO.

Read More
2 February 2023
AB Biotek works with Magnitude Biosciences to accelerate probiotic development
Guillermo Navarrete
No Comments

Magnitude Biosciences partnered with AB Biotek Human Nutrition & Health (ABB HNH), the global leader in yeast probiotics and postbiotics. Recently we had the pleasure of hosting Maria Tintoré and Carlos de Lecea from AB Biotek at our lab in Sedgefield, UK. There is growing evidence on how health problems and diseases are linked to […]

Read More
2 February 2023
Case Study - AB Biotek works with Magnitude Biosciences to accelerate probiotic development
Guillermo Navarrete
No Comments

Download the full case study here and learn how AB Biotek and Magnitude Biosciences collaborate to develop a new generation of probiotics.

Read More
5 December 2022
Pharmaceutical company Lundbeck in collaboration with Magnitude Biosciences on innovative new platform to test interventions for neurodegenerative disease
Jessica Evans
No Comments

Lundbeck collaborates with Magnitude on innovate platform to test neurodegenerative disease interventions

Read More
15 November 2022
Magnitude Biosciences secures new investment to accelerate scaling of its specialist anti-ageing research services
Mira Nair
No Comments

Magnitude Biosciences Limited, a specialist provider of C. elegans research services to the longevity, nutraceuticals and pharmaceutical industries, has closed a fourth round of investment to accelerate the scaling of its business.

Read More
AB Biotek works with Magnitude Biosciences to accelerate probiotic development
Guillermo Navarrete Feb 2, 2023
Magnitude Biosciences partnered with AB Biotek Human Nutrition & Health (ABB HNH), the global le...Read More
, ,
Pharmaceutical company Lundbeck in collaboration with Magnitude Biosciences on innovative new platform to test interventions for neurodegenerative disease
Jessica Evans Dec 5, 2022
Lundbeck collaborates with Magnitude on innovate platform to test neurodegenerative disease interven...Read More
Magnitude Biosciences secures new investment to accelerate scaling of its specialist anti-ageing research services
Mira Nair Nov 15, 2022
Magnitude Biosciences Limited, a specialist provider of C. elegans research services to the longevit...Read More
CEO and CSO of Magnitude Biosciences
Magnitude Biosciences Appoints New CEO Fozia Saleem to Drive Growth
Jessica Evans Oct 7, 2022
North East UK Biotech Magnitude Biosciences announces new CEO, Fozia Saleem, to accelerate the growt...Read More
C. elegans capabilities in the toxicology field
Guillermo Navarrete Sep 26, 2022
C. elegans is a proven model for toxicology research and has numerous advantages over other animal m...Read More
, , ,
SMER28 Extends Healthspan – Revealing a New Target for Ageing Therapeutics
Jessica Evans Sep 18, 2022
Biotech entrepreneur Ethan Perlstein works with Magnitude Biosciences to reveal a new target for age...Read More
1 2 3 … 5
AB Biotek works with Magnitude Biosciences to accelerate probiotic development
Guillermo Navarrete Feb 2, 2023
Magnitude Biosciences partnered with AB Biotek Human Nutrition & Health (ABB HNH), the global le...Read More
, ,
Case Study - AB Biotek works with Magnitude Biosciences to accelerate probiotic development
Guillermo Navarrete Feb 2, 2023
Download the full case study here and learn how AB Biotek and Magnitude Biosciences collaborate to d...Read More
Pharmaceutical company Lundbeck in collaboration with Magnitude Biosciences on innovative new platform to test interventions for neurodegenerative disease
Jessica Evans Dec 5, 2022
Lundbeck collaborates with Magnitude on innovate platform to test neurodegenerative disease interven...Read More
Magnitude Biosciences secures new investment to accelerate scaling of its specialist anti-ageing research services
Mira Nair Nov 15, 2022
Magnitude Biosciences Limited, a specialist provider of C. elegans research services to the longevit...Read More
1 2 3 … 11

News and blog

The latest from
Magnitude Biosciences

Blog Postnews
AB Biotek works with Magnitude Biosciences to accelerate probiotic development
Blog PostResources
Pharmaceutical company Lundbeck in collaboration with Magnitude Biosciences on innovative new platform to test interventions for neurodegenerative disease
Blog PostPress Release
Magnitude Biosciences secures new investment to accelerate scaling of its specialist anti-ageing research services
Blog PostPress Release
CEO and CSO of Magnitude Biosciences
Magnitude Biosciences Appoints New CEO Fozia Saleem to Drive Growth
Blog Post
C. elegans capabilities in the toxicology field
Blog PostPress Release
SMER28 Extends Healthspan – Revealing a New Target for Ageing Therapeutics
Blog Post
Ageing drug discovery biotech sees exciting early in vivo data for lead compound
Press Release
Magnitude Biosciences CEO David Weinkove appointed new Chair of British Society for Research on Ageing
newsPublication
Frontiers in Aging: Applying C. elegans to industrial drug discovery
Press Release
Magnitude Biosciences, Perfectus Biomed Group and University of Kent Project Funded by National Biofilms Innovation Centre for Tackling and Exploiting...

CONTACT US

Get in touch today to find out how we can support you to accelerate your research

CONTACT US

Get in touch today to find out how we can 
support you to accelerate your research
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram